Skip NavigationSkip to Content

4-Hydroxy-5,6-Dihydropyrones .2. Potent Non-Peptide Inhibitors of Hiv Protease

  1. Author:
    Tait, B. D.
    Hagen, S.
    Domagala, J.
    Ellsworth, E. L.
    Gajda, C.
    Hamilton, H. W.
    Prasad, J.
    Ferguson, D.
    Graham, N.
    Hupe, D.
    Nouhan, C.
    Tummino, P. J.
    Humblet, C.
    Lunney, E. A.
    Pavlovsky, A.
    Rubin, J.
    Gracheck, S. J.
    Baldwin, E. T.
    Bhat, T. N.
    Erickson, J. W.
    Gulnik, S. V.
    Liu, B. S.
  2. Author Address

    Tait BD WARNER LAMBERT PARKE DAVIS PARKE DAVIS PHARMACEUT RES DIV DEPT CHEM 2800 PLYMOUTH RD ANN ARBOR, MI 48105 USA WARNER LAMBERT PARKE DAVIS PARKE DAVIS PHARMACEUT RES DIV DEPT BIOCHEM ANN ARBOR, MI 48105 USA WARNER LAMBERT PARKE DAVIS PARKE DAVIS PHARMACEUT RES DIV DEPT BIOMOL STRUCT & DRUG DESIGN ANN ARBOR, MI 48105 USA NCI FREDERICK CANC RES & DEV CTR DYNCORP PRI STRUCT BIOCHEM PROGRAM FREDERICK, MD 21702 USA
    1. Year: 1997
  1. Journal: Journal of Medicinal Chemistry
    1. 40
    2. 23
    3. Pages: 3781-3792
  2. Type of Article: Article
  1. Abstract:

    The 4-hydroxy-5,6-dihydropyrone template was utilized as a flexible scaffolding from which to build potent active site inhibitors of HIV protease. Dihydropyrone Ic (5,6-dihydro-4-hydroxy-6-phenyl-3-[(2-phenylethyl)thio]-2H-pyran-2-o ne) was modeled in the active site of HIV protease utilizing a similar binding mode found for the previously reported 4-hydroxybenzopyran-2-ones. Our model led us to pursue the synthesis of 6,6-disubstituted dihydropyrones with the aim of filling S-1 and S-2 and thereby increasing the potency of the parent dihydropyrone Ic which did not fill S-2. Toward this end we attached various hydrophobic and hydrophilic side chains at the 6-position of the dihydropyrone to mimic the natural and unnatural amino acids known to be effective substrates at P-2 and P-2'. Parent dihydropyrone Ic (IC50 = 2100 nM) was elaborated into compounds with greater than a 100-fold increase in potency [18c, IC50 = 5 nM, 5-(3,6-dihydroxy-6-hydroxy-6-oxo-2-phenyl-5-[2-phenylethyl)thio]-2H- pyran-2-yl)pentanoic acid and 12c, IC50 = 51 nM, 5,6-dihydro-4-hydroxy-6-phenyl-6-(2-phenylethyl)thio]-2H-pyran-2-one ]. Optimization of the 3-position fragment to fill S-1' and S-2' afforded potent HIV protease inhibitor 49 [IC50 = 10 nM, 3-[(2-tert-butyl-5-methylphenyl)sulfanyl]-5,6-dihydro-4-hydroxy-6-ph enyl-6-(2-phenylethyl)-2H-pyran-2-one]. The resulting low molecular weight compounds (<475) have one or no chiral centers and are readily synthesized. [References: 36]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel